Clinical Trials · NCT00502138
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University Diabetes & Endocrine Consultants
- Enrollment
- 12
- Start date
- Jul 2007
- Locations
- 1 site, United States
- Primary endpoint
- Fasting and postprandial pramlintide pharmacokinetics